Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1

Journal of Nutritional Biochemistry

Volumn 23, Issue 4, 2012, Pages 349-360

  Guo, Honghui ^a,b   Xia, Min ^a   Zou, Tangbin ^a   Ling, Wenhua ^a   Zhong, Ruimin ^b   Zhang, Weiguo ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SHAOGUAN UNIVERSITY   (China)

Author keywords

Anthocyanin; C Jun N terminal kinase; Forkhead box O1; Hepatic steatosis; Inflammation; Insulin resistance

Indexed keywords

CYANIDIN 3 GLUCOSIDE; GLUCOSE; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR FKHR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DIET SUPPLEMENTATION; FATTY LIVER; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MACROPHAGE; MOUSE; NONHUMAN; OBESITY; PROTEIN PHOSPHORYLATION; WHITE ADIPOSE TISSUE;

ADIPOKINES; ADIPOSE TISSUE, WHITE; ANIMALS; ANTHOCYANINS; CHEMOKINE CCL2; DIET, HIGH-FAT; DIETARY FATS; FATTY LIVER; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSIDES; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; SIGNAL TRANSDUCTION; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84858290692     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.12.013     Document Type: Article

References (45)

1. Nishimura S., Manabe I., Nagai R. Adipose tissue inflammation in obesity and metabolic syndrome. Discov Med 2009, 8:55-60.
2. Zou C., Shao J. Role of adipocytokines in obesity-associated insulin resistance. J Nutr Biochem 2008, 19:277-286.
3. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
4. De Taeye B.M., Novitskaya T., McGuinness O.P., Gleaves L., Medda M., Covington J.W., et al. Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am J Physiol Endocrinol Metab 2007, 293:E713-E725.
5. Alwayn I.P., Andersson C., Lee S., Arsenault D.A., Bistrian B.R., Gura K.M., et al. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. Am J Physiol Gastrointest Liver Physiol 2006, 291:G1011-G1019.
6. Targher G., Bertolini L., Scala L., Poli F., Zenari L., Falezza G. Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals. Clin Endocrinol (Oxf) 2004, 61:700-703.
7. Nakae J., Biggs W.H., Kitamura T., Cavenee W.K., Wright C.V., Arden K.C., et al. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 2002, 32:245-253.
8. Matsumoto M., Pocai A., Rossetti L., Depinho R.A., Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab 2007, 6:208-216.
9. Nakae J., Kitamura T., Kitamura Y., Biggs W.H., Arden K.C., Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell 2003, 4:119-129.
10. Essers M.A., Weijzen S., de Vries-Smits A.M., Saarloos I., de Ruiter N.D., Bos J.L., et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J 2004, 23:4802-4812.
11. Shen B., Chao L., Chao J. Pivotal role of JNK-dependent FOXO1 activation in downregulation of kallistatin expression by oxidative stress. Am J Physiol Heart Circ Physiol 2010, 298:H1048-H1054.
12. Zhao X., Gan L., Pan H., Kan D., Majeski M., Adam S.A., et al. Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. Biochem J 2004, 378:839-849.
13. Matsumoto M., Han S., Kitamura T., Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 2006, 116:2464-2472.
14. Nakae J., Cao Y., Oki M., Orba Y., Sawa H., Kiyonari H., et al. Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure. Diabetes 2008, 57:563-576.
15. Kim J.J., Li P., Huntley J., Chang J.P., Arden K.C., Olefsky J.M. FoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissue. Diabetes 2009, 58:1275-1282.
16. Ito Y., Daitoku H., Fukamizu A. Foxo1 increases pro-inflammatory gene expression by inducing C/EBPbeta in TNF-alpha-treated adipocytes. Biochem Biophys Res Commun 2009, 378:290-295.
17. Galvano F., La Fauci L., Lazzarino G., Fogliano V., Ritieni A., Ciappellano S., et al. Cyanidins: metabolism and biological properties. J Nutr Biochem 2004, 15:2-11.
18. He J., Giusti M.M. Anthocyanins: natural colorants with health-promoting properties. Annu Rev Food Sci Technol 2010, 1:163-187.
19. Wang Q., Xia M., Liu C., Guo H., Ye Q., Hu Y., et al. Cyanidin-3-O-beta-glucoside inhibits iNOS and COX-2 expression by inducing liver × receptor alpha activation in THP-1 macrophages. Life Sci 2008, 83:176-184.
20. Xia M., Ling W., Zhu H., Wang Q., Ma J., Hou M., et al. Anthocyanin prevents CD40-activated proinflammatory signaling in endothelial cells by regulating cholesterol distribution. Arterioscler Thromb Vasc Biol 2007, 27:519-524.
21. 2- or TNF-alpha-induced insulin resistance by inhibiting c-Jun NH2-terminal kinase activation. Biochem Pharmacol 2008, 75:1393-1401.
22. Tsuda T., Horio F., Uchida K., Aoki H., Osawa T. Dietary cyanidin 3-O-beta-d-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J Nutr 2003, 133:2125-2130.
23. Guo H., Ling W., Wang Q., Liu C., Hu Y., Xia M., et al. Effect of anthocyanin-rich extract from black rice (Oryza sativa L. indica) on hyperlipidemia and insulin resistance in fructose-fed rats. Plant Foods Hum Nutr 2007, 62:1-6.
24. Jayaprakasam B., Olson L.K., Schutzki R.E., Tai M.H., Nair M.G. Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). J Agric Food Chem 2006, 54:243-248.
25. Takikawa M., Inoue S., Horio F., Tsuda T. Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J Nutr 2010, 140:527-533.
26. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
27. Levy J.C., Matthews D.R., Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998, 21:2191-2192.
28. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
29. Alessi M.C., Bastelica D., Mavri A., Morange P., Berthet B., Grino M., et al. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler Thromb Vasc Biol 2003, 23:1262-1268.
30. Kobayashi K., Forte T.M., Taniguchi S., Ishida B.Y., Oka K., Chan L. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism 2000, 49:22-31.
31. Nguyen M.T., Satoh H., Favelyukis S., Babendure J.L., Imamura T., Sbodio J.I., et al. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem 2005, 280:35361-35371.
32. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., et al. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
33. Xia M., Ling W., Zhu H., Ma J., Wang Q., Hou M., et al. Anthocyanin attenuates CD40-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced MAPK activation. Atherosclerosis 2009, 202:41-47.
34. Matsuzaki H., Daitoku H., Hatta M., Tanaka K., Fukamizu A. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc Natl Acad Sci U S A 2003, 100:11285-11290.
35. Aoyama H., Daitoku H., Fukamizu A. Nutrient control of phosphorylation and translocation of Foxo1 in C57BL/6 and db/db mice. Int J Mol Med 2006, 18:433-439.
36. Zhang W., Patil S., Chauhan B., Guo S., Powell D.R., Le J., et al. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem 2006, 281:10105-10117.
37. Wang L.S., Stoner G.D. Anthocyanins and their role in cancer prevention. Cancer Lett 2008, 269:281-290.
38. Sasaki R., Nishimura N., Hoshino H., Isa Y., Kadowaki M., Ichi T., et al. Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochem Pharmacol 2007, 74:1619-1627.
39. Qin Y., Xia M., Ma J., Hao Y., Liu J., Mou H., et al. Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects. Am J Clin Nutr 2009, 90:485-492.
40. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006, 116:1494-1505.
41. de Alvaro C., Teruel T., Hernandez R., Lorenzo M. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem 2004, 279:17070-17078.
42. Seymour E.M., Lewis S.K., Urcuyo-Llanes D.E., Tanone I.I., Kirakosyan A., Kaufman P.B., et al. Regular tart cherry intake alters abdominal adiposity, adipose gene transcription, and inflammation in obesity-prone rats fed a high fat diet. J Med Food 2009, 12:935-942.
43. Lumeng C.N., Deyoung S.M., Saltiel A.R. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol Endocrinol Metab 2007, 292:E166-E174.
44. Gross D.N., Wan M., Birnbaum M.J. The role of FOXO in the regulation of metabolism. Curr Diab Rep 2009, 9:208-214.
45. Altomonte J., Richter A., Harbaran S., Suriawinata J., Nakae J., Thung S.N., et al. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am J Physiol Endocrinol Metab 2003, 285:E718-E728.